154 related articles for article (PubMed ID: 12750292)
1. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity.
Anilkumar G; Rajasekaran SA; Wang S; Hankinson O; Bander NH; Rajasekaran AK
Cancer Res; 2003 May; 63(10):2645-8. PubMed ID: 12750292
[TBL] [Abstract][Full Text] [Related]
2. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.
Ghosh A; Heston WD
J Cell Biochem; 2004 Feb; 91(3):528-39. PubMed ID: 14755683
[TBL] [Abstract][Full Text] [Related]
3. Is prostate-specific membrane antigen a multifunctional protein?
Rajasekaran AK; Anilkumar G; Christiansen JJ
Am J Physiol Cell Physiol; 2005 May; 288(5):C975-81. PubMed ID: 15840561
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction.
Conway RE; Petrovic N; Li Z; Heston W; Wu D; Shapiro LH
Mol Cell Biol; 2006 Jul; 26(14):5310-24. PubMed ID: 16809768
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
Lupold SE; Hicke BJ; Lin Y; Coffey DS
Cancer Res; 2002 Jul; 62(14):4029-33. PubMed ID: 12124337
[TBL] [Abstract][Full Text] [Related]
6. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).
Luthi-Carter R; Barczak AK; Speno H; Coyle JT
J Pharmacol Exp Ther; 1998 Aug; 286(2):1020-5. PubMed ID: 9694964
[TBL] [Abstract][Full Text] [Related]
10. Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen.
Ghosh A; Heston WD
Prostate; 2003 Oct; 57(2):140-51. PubMed ID: 12949938
[TBL] [Abstract][Full Text] [Related]
11. Binding of filamin to the C-terminal tail of the calcitonin receptor controls recycling.
Seck T; Baron R; Horne WC
J Biol Chem; 2003 Mar; 278(12):10408-16. PubMed ID: 12531889
[TBL] [Abstract][Full Text] [Related]
12. A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen.
Rajasekaran SA; Anilkumar G; Oshima E; Bowie JU; Liu H; Heston W; Bander NH; Rajasekaran AK
Mol Biol Cell; 2003 Dec; 14(12):4835-45. PubMed ID: 14528023
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA).
Tino WT; Huber MJ; Lake TP; Greene TG; Murphy GP; Holmes EH
Hybridoma; 2000 Jun; 19(3):249-57. PubMed ID: 10952413
[TBL] [Abstract][Full Text] [Related]
14. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.
Dyson JM; O'Malley CJ; Becanovic J; Munday AD; Berndt MC; Coghill ID; Nandurkar HH; Ooms LM; Mitchell CA
J Cell Biol; 2001 Dec; 155(6):1065-79. PubMed ID: 11739414
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells.
Lapidus RG; Tiffany CW; Isaacs JT; Slusher BS
Prostate; 2000 Dec; 45(4):350-4. PubMed ID: 11102961
[TBL] [Abstract][Full Text] [Related]
16. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
17. Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu H; Rajasekaran AK; Moy P; Xia Y; Kim S; Navarro V; Rahmati R; Bander NH
Cancer Res; 1998 Sep; 58(18):4055-60. PubMed ID: 9751609
[TBL] [Abstract][Full Text] [Related]
18. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH
Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653
[TBL] [Abstract][Full Text] [Related]
20. Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
Mhaka A; Gady AM; Rosen DM; Lo KM; Gillies SD; Denmeade SR
Cancer Biol Ther; 2004 Jun; 3(6):551-8. PubMed ID: 15044850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
